Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Cemiplimab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428550798/en/Ankyra-Therapeutics-Announces-Phase-1-Clinical-Data-at-the-2025-AACR-Annual-Meeting-and-the-first-patient-has-been-dosed-with-tolododekin-alfa-and-cemiplimab

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Regeneron lays out bright future for newest blockbuster Libtayo
    Regeneron lays out bright future for newest blockbuster Libtayo

    05 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/regenerons-libtayo-reaches-blockbuster-status-and-has-potential-more-growth

    FIERCE PHARMA
    05 Feb 2025
    Share Share
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer

    04 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250204174307/en

    BUSINESSWIRE
    04 Feb 2025
    Share Share
    Adjuvant Libtayo® Improves DFS In High-Risk CSCC In Phase 3 Trial
    Adjuvant Libtayo® Improves DFS In High-Risk CSCC In Phase 3 Trial

    13 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/13/3008232/0/en/Adjuvant-Libtayo-cemiplimab-Significantly-Improves-Disease-Free-Survival-DFS-After-Surgery-in-High-Risk-Cutaneous-Squamous-Cell-Carcinoma-CSCC-in-Phase-3-Trial.html

    GLOBENEWSWIRE
    13 Jan 2025
    Share Share
    Palleon Pharma GLIMMER-01 E-602 + Cemiplimab Data at SITC
    Palleon Pharma GLIMMER-01 E-602 + Cemiplimab Data at SITC

    08 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241108273263/en

    BUSINESSWIRE
    08 Nov 2024
    Share Share
    MAIA Announces Positive THIO Phase 2 Survival Updates
    MAIA Announces Positive THIO Phase 2 Survival Updates

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910368128/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share